GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello A/S (OTCPK:AKBLF) » Definitions » Institutional Ownership

Alk-Abello A/S (Alk-Abello A/S) Institutional Ownership : 19.25% (As of Jun. 07, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Alk-Abello A/S Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alk-Abello A/S's institutional ownership is 19.25%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alk-Abello A/S's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alk-Abello A/S's Float Percentage Of Total Shares Outstanding is 0.00%.


Alk-Abello A/S Institutional Ownership Historical Data

The historical data trend for Alk-Abello A/S's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello A/S Institutional Ownership Chart

Alk-Abello A/S Historical Data

The historical data trend for Alk-Abello A/S can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 16.88 17.51 18.37 17.95 17.69 18.55 18.48 18.63 19.22 19.25

Alk-Abello A/S Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Alk-Abello A/S (Alk-Abello A/S) Business Description

Traded in Other Exchanges
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello A/S (Alk-Abello A/S) Headlines

From GuruFocus